Innovative Diagnostic Platform Abionic's flagship abioSCOPE® platform offers rapid, lab-quality diagnostic results from a single drop of blood at the point-of-care, presenting opportunities to target healthcare providers seeking efficient and accurate testing solutions.
Award-Winning Credibility Having received the Swiss MedTech of the Year award in 2023 and multiple industry accolades, Abionic demonstrates strong credibility and market recognition, easing engagement with institutional buyers and partners.
Strategic Collaborations Recent partnership agreements, such as with Fapon Biotech Inc, highlight Abionic’s openness to strategic alliances, opening avenues for co-marketing, distribution, and technology integration opportunities.
Expansion in Critical COVID-19 Testing Abionic’s development of quick COVID-19 severity tests like cSOFA presents sales opportunities within hospitals and public health sectors looking for effective pandemic management tools.
Growing Leadership and Innovation With recent leadership changes and continuous product launches, Abionic is positioned as an innovative and adaptable company, appealing to investors and channel partners interested in cutting-edge medical diagnostics.
Abionic uses 8 technology products and services including MATLAB, Fusion Ads, Unpkg, and more. Explore Abionic's tech stack below.
| Abionic Email Formats | Percentage |
| First.Last@abionic.com | 49% |
| First@abionic.com | 1% |
| FLast@abionic.com | 1% |
| First.Last@abionic.com | 49% |
Medical Equipment ManufacturingSwitzerland11-50 Employees
The winner of multiple industry awards, including "Swiss MedTech of the year" in 2023, Abionic is a Swiss MedTech company spun-out of EPFL in 2010 on a vision nanofluidics could transform diagnostics. Our flagship abioSCOPE®, a near-patient rapid diagnostic platform, delivers lab-quality results from a drop of blood within minutes, providing valuable clinical insights and actionable information at the point-of-care.
Company Overview
Media & News
Funding & FinancialsAbionic has raised a total of $83K of funding over 9 rounds. Their latest funding round was raised on Jun 13, 2023 in the amount of $83K.
Abionic's revenue is estimated to be in the range of $1M
Funding & FinancialsAbionic has raised a total of $83K of funding over 9 rounds. Their latest funding round was raised on Jun 13, 2023 in the amount of $83K.
Abionic's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com